World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
117
Citations
70920
World Ranking
4127
National Ranking
2260

Overview

Christopher L. Corless is affiliated with Oregon Health & Science University in the United States. Their research spans multiple fields including Medicine and Biochemistry, Genetics and Molecular Biology, with a particular focus on subfields such as Pulmonary and Respiratory Medicine, Oncology, Gastroenterology, Molecular Biology, and Cancer Research.

The scientist's work addresses a variety of main topics, specifically:

  • Gastrointestinal Tumor Research and Treatment
  • Cancer Genomics and Diagnostics
  • Sarcoma Diagnosis and Treatment
  • Gastrointestinal Disorders and Treatments
  • PARP Inhibition in Cancer Therapy
  • Advanced Breast Cancer Therapies
  • Gastric Cancer Management and Outcomes

Christopher L. Corless has contributed publications to a range of prominent venues. The most frequent among these include:

  • Journal of Clinical Oncology
  • Cancer Research
  • Annals of Surgical Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • JCO Precision Oncology

Among their recent papers are the following:

  • Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor, 2023, Journal of Clinical Oncology
  • SHIFT: speedy histological-to-immunofluorescent translation of a tumor signature enabled by deep learning, 2020, Scientific Reports
  • Recurrent RET gene fusions in paediatric spindle mesenchymal neoplasms*, 2020, Histopathology
  • Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin, 2020, UNC Libraries
  • Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcoma, 2021, Modern Pathology

Christopher L. Corless frequently collaborates with other researchers, including:

  • Gordon B. Mills
  • Joe W. Gray
  • Michael C. Heinrich
  • Brett Johnson
  • Zahi Mitri

Best Publications

  • Diagnosis of gastrointestinal stromal tumors: A consensus approach.

    Christopher D.M. Fletcher;Jules J. Berman;Christopher Corless;Fred Gorstein

  • Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.

    George Daniel Demetri;Margaret von Mehren;Charles D. Blanke;Annick Diane Van Den Abbeele

  • PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors

    Michael C. Heinrich;Christopher L. Corless;Anette Duensing;Laura McGreevey

  • Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor

    Michael C. Heinrich;Christopher L. Corless;George D. Demetri;Charles D. Blanke

  • Biology of gastrointestinal stromal tumors.

    Christopher L. Corless;Jonathan A. Fletcher;Michael C. Heinrich

  • Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing KIT

    Charles D Blanke;George D Demetri;Margaret von Mehren;Michael C Heinrich

  • NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.

    George D. Demetri;Robert S. Benjamin;Charles D. Blanke;Jean Yves Blay

  • PDGFRA Mutations in Gastrointestinal Stromal Tumors: Frequency, Spectrum and In Vitro Sensitivity to Imatinib

    Christopher L. Corless;Arin Schroeder;Diana Griffith;Ajia Town

  • Molecular Correlates of Imatinib Resistance in Gastrointestinal Stromal Tumors

    Michael C. Heinrich;Christopher L. Corless;Charles D. Blanke;George D. Demetri

  • Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO

    Jean Yves Blay;Sylvie Bonvalot;Paolo Casali;Haesun Choi

  • Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor

    Michael C. Heinrich;Robert G. Maki;Christopher L. Corless;Cristina R. Antonescu

  • Gastrointestinal stromal tumours: origin and molecular oncology

    Christopher L. Corless;Christine M. Barnett;Michael C. Heinrich

  • Gastrointestinal stromal tumour

    Brian P Rubin;Michael C Heinrich;Michael C Heinrich;Christopher L Corless;Christopher L Corless

  • The Novel Marker, DOG1, Is Expressed Ubiquitously in Gastrointestinal Stromal Tumors Irrespective of KIT or PDGFRA Mutation Status

    Robert B. West;Christopher L Corless;Xin Chen;Brian P. Rubin

  • Inhibition of KIT Tyrosine Kinase Activity: A Novel Molecular Approach to the Treatment of KIT-Positive Malignancies

    Michael C. Heinrich;Charles D. Blanke;Brian J. Druker;Christopher L. Corless

  • Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboring c-Kit Mutation or Amplification

    Jun Guo;Lu Si;Yan Kong;Keith T. Flaherty

  • Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205

    Philip A. Philip;Jacqueline Benedetti;Christopher L. Corless;Ralph Wong

  • Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group.

    Michael C. Heinrich;Kouros Owzar;Christopher L. Corless;Donna Hollis

  • KIT Gene Mutations and Copy Number in Melanoma Subtypes

    Carol Beadling;Erick Jacobson-Dunlop;F. Stephen Hodi;Claudia Le

  • KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications.

    Fabiola Medeiros;Christopher L Corless;Anette Duensing;Jason L Hornick

Frequent Co-Authors

Michael Heinrich
Michael Heinrich Oregon Health & Science University
Jonathan A. Fletcher
Jonathan A. Fletcher Brigham and Women's Hospital
George D. Demetri
George D. Demetri Dana-Farber Cancer Institute
Hugo R. Rosen
Hugo R. Rosen University of Southern California
Brian P. Rubin
Brian P. Rubin Cleveland Clinic
Christopher D.M. Fletcher
Christopher D.M. Fletcher Brigham and Women's Hospital
Joe W. Gray
Joe W. Gray Oregon Health & Science University
Gordon B. Mills
Gordon B. Mills Oregon Health & Science University
Charles D. Blanke
Charles D. Blanke Oregon Health & Science University
Margaret von Mehren
Margaret von Mehren Fox Chase Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA can open doors to a wide range of health-focused careers, many of which allow for flexible study paths. Aspiring nurses interested in a less traditional entry route may consider enrolling in a nursing school that doesn't require teas, offering accessibility for those who wish to skip certain standardized exams.

For those targeting leadership roles in hospitals, clinics, or public health, an online healthcare administration degree can be a smart and efficient step. This pathway equips students with the managerial skills needed to improve healthcare systems and patient outcomes.

Registered nurses eager to advance further might explore adn to np programs online. These bridge programs help nurses earn advanced degrees in less time, leading to higher qualifications such as nurse practitioner.

Nutrition is another growing field. The best online nutrition programs prepare graduates to become valuable experts in dietetics, wellness coaching, and nutrition science, all vitally important to modern healthcare teams.

Best Scientists Citing Christopher L. Corless

Trending Scientists